The concept of plaque sealing was finally tested and the results just published in Circulation.
The results: "Stenting moderate nonsignificant lesions in old SVGs (bypass grafts) with PES (a drug eluting stent) was associated with a lower rate of SVG (bypass graft) disease progression and a trend toward a lower incidence of major adverse cardiac events at 1-year follow-up compared with medical treatment alone, despite very low low-density lipoprotein cholesterol values.
This study represent what I hope is the first of many studies looking at this novel concept.
No comments:
Post a Comment